The FDA recently launched the expansion of its Total Product Life Cycle Advisory Program (TAP), which was initiated in 2023. While the program was first launched to hasten the development of high-quality medical devices for cardiology and neurology, it is now being expanded to include radiology and ophthalmology.
The FDA is looking to better coordinate communication between device manufacturers, physician societies, payers, patient advocates and other related groups, with the goal of making high-quality medical devices more accessible to physicians and their patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
